Joel Greenblatt’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23,516
Closed -$459K – 1947
2026
Q2
$459K Sell
23,516
-1,986
-8% -$39.4K ﹤0.01% 1535
2026
Q1
$490K Sell
25,502
-455
-2% -$8.96K ﹤0.01% 1493
2025
Q4
$492K Sell
25,957
-1,096
-4% -$20.3K ﹤0.01% 1444
2025
Q3
$504K Buy
27,053
+114
+0.4% +$2.13K ﹤0.01% 1378
2025
Q2
$497K Buy
26,939
+1,083
+4% +$19.2K ﹤0.01% 1324
2025
Q1
$452K Buy
25,856
+11,495
+80% +$194K ﹤0.01% 1263
2024
Q4
$249K Sell
14,361
-640
-4% -$11.7K ﹤0.01% 1314
2024
Q3
$279K Buy
15,001
+91
+0.6% +$1.53K ﹤0.01% 1257
2024
Q2
$230K Buy
14,910
+1,312
+10% +$18.7K ﹤0.01% 1300
2024
Q1
$201K Buy
13,598
+1,808
+15% +$25K ﹤0.01% 1289
2023
Q4
$168K Buy
+11,790
New +$167K ﹤0.01% 1269
2020
Q4
– Sell
-11,625
Closed -$160K – 1088
2020
Q3
$160K Buy
11,625
+95
+0.8% +$1.4K 0.01% 958
2020
Q2
$166K Sell
11,530
-6,552
-36% -$86.1K 0.01% 981
2020
Q1
$197K Buy
+18,082
New +$333K 0.01% 945

Other funds holding SBRA

Joel Greenblatt's SBRA Position: Q3 2026 in Review

Joel Greenblatt sold out of Sabra Healthcare REIT (SBRA) in Q3 2026, closing a stake of 23,516 shares — an estimated $459K sold.

Joel Greenblatt first reported a position in SBRA in Q1 2020 and held it in 14 quarters. The position peaked at $504K in Q3 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q3 2026.

  • Joel Greenblatt reported no remaining Sabra Healthcare REIT position as of Q3 2026 after selling out during the quarter.
  • Joel Greenblatt sold 23,516 Sabra Healthcare REIT shares in Q3 2026, an estimated $459K.
  • Joel Greenblatt first reported a position in Sabra Healthcare REIT in Q1 2020 and held it in 14 quarters.
  • Joel Greenblatt's Sabra Healthcare REIT position peaked at $504K in Q3 2025.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.